Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
138 studies found for:    Open Studies | "Protozoan Infections"
Show Display Options
RSS Create an RSS feed from your search for:
Open Studies | "Protozoan Infections"
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting Malaria Elimination Pilot Study in Military Forces in Cambodia
Conditions: Malaria;   Parasitic Diseases
Interventions: Drug: DHA-PIP;   Drug: Primaquine;   Drug: Artesunate + Mefloquine;   Drug: Permethrin (Insecticide treated uniform)
2 Recruiting Demographic Surveillance to Monitor Impact of Malaria on Pregnant Women in Ouelessebougou, Mali
Condition: Malaria
Intervention:
3 Recruiting Safety and Immunogenicity of Pfs25M-EPA/AS01 and Pfs230D1M-EPA/AS01 Vaccines, Transmission Blocking Vaccines Against Plasmodium Falciparum, at Full and Fractional Dosing in Adults in Mali
Condition: Malaria
Interventions: Biological: Pfs25M-EPA/AS01;   Biological: Pfs230D1M-EPA/AS01;   Other: AS01;   Biological: Bexsero (Comparator Vaccine);   Biological: Fluarix;   Other: Normal Saline;   Drug: Coartem
4 Not yet recruiting Efficacy and Safety of Artemisinin-based Combination Treatments in the Democratic Republic of the Congo
Condition: Malaria
Interventions: Drug: artesunate-amodiaquine;   Drug: artemether-lumefantrine;   Drug: Dihydroartemisinine-piperaquine
5 Not yet recruiting Field Efficacy Of Insecticide Treated Uniforms And Skin Repellents for Malaria Prevention
Condition: Malaria
Interventions: Other: Ultra 30 Insect Repellent Lotion (30% Lipo DEET);   Other: Permethrin Factory-Treated Army Combat Uniforms;   Other: Placebo lotion;   Other: Army combat uniform
6 Not yet recruiting Field Evaluation of a Device for Automated Malaria Microscopy (Autoscope Version 2)
Condition: Malaria
Intervention:
7 Recruiting A Challenge Study to Assess the Safety, Immunogenicity and Efficacy of a Malaria Vaccine Candidate
Condition: Malaria
Intervention: Biological: RH5.1/ ASO1
8 Recruiting A Study to Assess the Safety and Immunogenicity of the Malaria Vaccine, R21, With Matrix-M1 Adjuvant
Condition: Malaria
Interventions: Biological: R21/Matrix-M1;   Other: Saline
9 Recruiting A Safety and Efficacy Study of R21 +/- ChAd63/MVA ME-TRAP
Condition: Malaria
Interventions: Biological: 10 µg R21/ 50 µg Matrix M1;   Biological: 50 µg R21/ 50 µg Matrix M1;   Biological: ChAd63 ME-TRAP;   Biological: MVA ME-TRAP;   Drug: Paracetamol;   Drug: Riamet;   Drug: Cyclizine;   Drug: Topical antihistamine
10 Not yet recruiting Metabolism and Pharmacokinetics of Primaquine Enantiomers in Human Volunteers, Study 1
Condition: Malaria
Intervention: Drug: Primaquine, R-Primaquine, S-Primaquine, SR Primaquine
11 Recruiting Prevalence Survey of Plasmodium Falciparum Antimalarial Drug Resistance Markers
Condition: Plasmodium Falciparum
Intervention:
12 Not yet recruiting MMV390048 POC in Patients With P. Vivax and P. Falciparum Malaria
Condition: Malaria
Intervention: Drug: MMV390048
13 Recruiting RHOST-cRCT, Reactive Household-based Self-administered Treatment Against Residual Malaria Transmission
Condition: Malaria
Intervention: Biological: dihydroartemisinin-piperaquine
14 Not yet recruiting G6PD Assessment Before Primaquine for Radical Treatment of Vivax Malaria
Condition: Vivax Malaria
Interventions: Drug: Chloroquine;   Drug: Primaquine 0.25 mg/kg/day;   Drug: Primaquine 0.75 mg/kg weekly
15 Recruiting SJ733 Induced Blood Stage Malaria Challenge Study
Condition: Plasmodium Falciparum Malaria
Intervention: Drug: (+)-SJ000557733
16 Not yet recruiting Safety, Tolerability and Immunogenicity of PfSPZ Vaccine in an Age De-escalation Trial in Equatorial Guinea.
Condition: Malaria
Interventions: Biological: PfSPZ Vaccine;   Biological: PfSPZ Challenge (for CHMI);   Other: Normal Saline;   Biological: PfSPZ Challenge (for PfSPZ-CVac)
17 Recruiting Methylene Blue Against Falciparum Malaria in Burkina Faso
Condition: Malaria, Falciparum
Interventions: Drug: Methylene Blue;   Drug: Primaquine
18 Recruiting Controlled Human Malaria Infection Model for Evaluation of Transmission‐Blocking Interventions - Study 1
Condition: Malaria
Interventions: Drug: Sulfadoxine-pyrimethamine (low dose);   Drug: Piperaquine (low dose);   Drug: Sulfadoxine-pyrimethamine (high dose);   Drug: Piperaquine (high dose);   Biological: malaria challenge infection, P. falciparum 3D7;   Drug: Atovaquone-proguanil
19 Not yet recruiting Efficacy and Safety Study of Tafenoquine (TQ) Co-administered With Dihydroartemisinin-piperaquine (DHA-PQP) for the Radical Cure of Plasmodium Vivax (P. Vivax) Malaria
Condition: Malaria, Vivax
Interventions: Drug: Tafenoquine;   Drug: Matched-Placebo for Tafenoquine;   Drug: Primaquine;   Drug: Matched-Placebo for Primaquine;   Drug: Dihydroartemisinin-piperaquine (DHA-PQP);   Drug: ACT plus PQ (Rescue medication);   Drug: PQ (End of study treatment)
20 Not yet recruiting Child Follow-up Until 2 Years
Conditions: Malaria;   Pregnancy
Intervention:

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.